You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 8, 2025

Drug Price Trends for COLESEVELAM


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for COLESEVELAM

Average Pharmacy Cost for COLESEVELAM

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
COLESEVELAM 625 MG TABLET 27808-0190-01 0.21945 EACH 2025-01-22
COLESEVELAM 625 MG TABLET 00713-0936-81 0.21945 EACH 2025-01-22
COLESEVELAM HCL 3.75 G PACKET 68462-0620-30 3.13652 EACH 2025-01-22
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for COLESEVELAM

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
COLESEVELAM HCL 625MG TAB AvKare, LLC 69452-0158-25 180 58.49 0.32494 EACH 2023-06-15 - 2028-06-14 FSS
COLESEVELAM HCL 625MG TAB Golden State Medical Supply, Inc. 51407-0336-18 180 33.80 0.18778 EACH 2023-06-15 - 2028-06-14 FSS
COLESEVELAM HCL 3.75GM PWDR,PKT Sun Pharmaceutical Industries, Inc. 51660-0995-30 30 49.47 1.64900 EACH 2024-01-01 - 2026-07-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for Colesevelam

Introduction to Colesevelam

Colesevelam, a bile acid sequestrant, is commonly used to lower low-density lipoprotein (LDL) cholesterol and to manage type 2 diabetes. It is available in both oral tablet and powder forms, with the brand-name version known as Welchol[5].

Market Size and Forecast

The global colesevelam market is anticipated to grow at a moderate pace over the next few years. Here are some key projections:

  • The market is expected to increase at a Compound Annual Growth Rate (CAGR) of 3 to 5 percent from 2024 to 2031, reaching an estimated valuation of several hundred million USD by 2031[3].
  • The base year for calculations is 2023, with historical data covering 2019-2023 and forecasted data extending from 2025 to 2031[1][3].

Market Segmentation

The colesevelam market is segmented based on several criteria:

  • Type: The market is categorized into segments such as 99% purity and other types. The 99% purity segment is expected to dominate due to its high efficacy and demand[3].
  • Application: The primary applications include lowering blood fat and aiding in weight loss. Lowering blood fat is the most significant application, given the drug's primary use in managing cholesterol levels[3].
  • Geography: The market is divided into regions such as North America, Europe, Asia-Pacific, South America, and the Middle East & Africa. North America is expected to be a major market due to high prevalence of cholesterol-related disorders and strong healthcare infrastructure[1][3].

Key Factors Affecting the Market

Several factors influence the colesevelam market:

  • Demand for Cholesterol Management: The increasing prevalence of high cholesterol and related cardiovascular diseases drives the demand for colesevelam[3].
  • Competition from Generics: The availability of generic versions of colesevelam can impact the market dynamics, as generics tend to be more affordable and thus more attractive to cost-conscious consumers[5].
  • Insurance Coverage and Patient Assistance Programs: The cost of colesevelam can vary significantly based on insurance coverage and patient assistance programs. Programs like Rx Outreach and HealthWell Foundation Copay Program help make the drug more accessible to low-income or uninsured individuals[2].

Pricing and Cost Considerations

The cost of colesevelam can be substantial, but there are several factors and strategies that can influence the price:

  • Form and Dosage: The drug is available in oral tablets (625 mg) and oral powder for reconstitution (3.75 g). The cost for a 30-day supply of the powder can range from $714.59 to $946.18, while a 180-tablet supply can cost between $714.59 and $946.18[2].
  • Generic vs. Brand-Name: The generic version of colesevelam is generally cheaper than the brand-name version, Welchol. The FDA approval of generic versions has made the drug more affordable for many patients[5].
  • Insurance and Patient Assistance: The actual cost to the patient can be significantly reduced with insurance coverage and patient assistance programs. For example, programs like Rx Outreach and HealthWell Foundation offer discounted or free medications to eligible individuals[2].

Regional Analysis

The global colesevelam market is geographically diverse, with different regions contributing to its growth:

  • North America: This region is expected to dominate the market due to a high prevalence of cholesterol-related disorders and a well-developed healthcare system[1][3].
  • Europe: Europe is another significant market, driven by an aging population and increasing health awareness[1][3].
  • Asia-Pacific: This region is expected to grow rapidly due to increasing healthcare expenditure and a large patient population[1][3].

Competitive Landscape

The colesevelam market is competitive, with several key players:

  • Apothecon Pharmaceuticals: Known for its generic pharmaceutical products, including colesevelam.
  • Formosa Laboratories: Another major player in the generic pharmaceutical market.
  • Solara Active Pharma Sciences: Specializes in active pharmaceutical ingredients and finished dosage forms, including colesevelam[3].

Market Trends and Drivers

Several trends and drivers are shaping the colesevelam market:

  • Increasing Prevalence of Cholesterol-Related Disorders: The rising incidence of high cholesterol and related cardiovascular diseases is a major driver of the market[3].
  • Advancements in Healthcare Infrastructure: Improvements in healthcare infrastructure, especially in developing regions, are expected to boost the market[1].
  • Cost-Effective Generic Options: The availability of generic versions of colesevelam is making the drug more accessible and affordable for a wider population[5].

Restraints and Challenges

Despite the growth potential, the colesevelam market faces several challenges:

  • High Development Costs: The development and approval process for pharmaceuticals is costly and time-consuming, which can affect the pricing and availability of the drug[5].
  • Regulatory Hurdles: Strict regulatory requirements can slow down the market growth and affect the profitability of manufacturers[4].
  • Side Effects and Safety Concerns: Like any medication, colesevelam can have side effects, which may impact patient compliance and market growth[5].

Technological Trends

Technological advancements are also influencing the colesevelam market:

  • Improved Manufacturing Processes: Advances in manufacturing technologies can lead to more efficient and cost-effective production of colesevelam[4].
  • Digital Health Solutions: The integration of digital health solutions can enhance patient compliance and monitoring, potentially improving the efficacy of the treatment[1].

Consumer Behavior Analysis

Consumer behavior plays a crucial role in the colesevelam market:

  • Health Awareness: Increasing health awareness among consumers is driving the demand for cholesterol management medications like colesevelam[1].
  • Cost Sensitivity: Patients are often cost-sensitive, which makes the availability of generic versions and patient assistance programs critical[2].

COVID-19 Impact

The COVID-19 pandemic has had a mixed impact on the colesevelam market:

  • Supply Chain Disruptions: The pandemic caused supply chain disruptions that affected the availability of medications, including colesevelam[1].
  • Increased Health Awareness: The pandemic also increased health awareness and the importance of preventive care, which could drive demand for cholesterol management medications[1].

Key Takeaways

  • The global colesevelam market is expected to grow at a CAGR of 3 to 5 percent from 2024 to 2031.
  • The market is segmented by type, application, and geography, with North America expected to dominate.
  • Generic versions of colesevelam are making the drug more affordable.
  • Patient assistance programs and insurance coverage significantly impact the cost to the patient.
  • Technological advancements and increasing health awareness are driving market growth.

FAQs

What is the primary use of colesevelam?

Colesevelam is primarily used to lower low-density lipoprotein (LDL) cholesterol and to manage type 2 diabetes[5].

How much does colesevelam cost?

The cost of colesevelam can vary, but for a 30-day supply of the powder, it can range from $714.59 to $946.18, and for a 180-tablet supply, it can range from $714.59 to $946.18[2].

Is there a generic version of colesevelam available?

Yes, a generic version of colesevelam has been approved by the FDA and is generally cheaper than the brand-name version, Welchol[5].

What are the key factors affecting the price of colesevelam?

The price of colesevelam can be affected by factors such as treatment plan, insurance coverage, and the pharmacy used. Patient assistance programs can also reduce the cost[2].

Which region is expected to dominate the global colesevelam market?

North America is expected to dominate the global colesevelam market due to a high prevalence of cholesterol-related disorders and a well-developed healthcare system[1][3].

Sources

  1. Cognitivemarketresearch.com: Colesevelam Market Report 2024 (Global Edition)
  2. Drugs.com: Welchol Prices, Coupons, Copay Cards & Patient Assistance
  3. Marketresearchintellect.com: Global Colesevelam Market Size And Forecast 2
  4. Marketresearchreports.com: Global Colesevelam Hydrochloride Market Research Report 2024
  5. Medicalnewstoday.com: Colesevelam cost 2024: Coupons and more

More… ↓

⤷  Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.